Parschauer Karah Herdman
EVP and Chief Legal Officer
Parschauer Karah Herdman has filed 7 SEC Form 4 filings (9 transaction rows) across 2 companies, including RARE, EOLS, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Aug 4, 2026.
On the most recent filing, Parschauer Karah Herdman is listed as EVP and Chief Legal Officer at Ultragenyx Pharmaceutical Inc. Inside the rolling window, Parschauer Karah Herdman reported no open-market purchases and 5 open-market sales totaling $488K in RARE. The largest disclosed transaction in the window is a sale of 8,135 RARE shares on Mar 2, 2026, worth $185K.
Companies traded
Other insiders at RARE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$488K
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 12, 2025 | RARE | Sale | $76K |
Frequently asked questions
How many SEC Form 4 filings has Parschauer Karah Herdman made?
Parschauer Karah Herdman has filed 7 SEC Form 4 filings (9 transaction rows) across 2 companies, including RARE, EOLS since 2025.
Which companies does Parschauer Karah Herdman trade?
Parschauer Karah Herdman has filed SEC Form 4 disclosures for 2 companies, including RARE, EOLS.
When was Parschauer Karah Herdman's most recent SEC Form 4 filing?
Parschauer Karah Herdman's most recent SEC Form 4 filing on Tracefour is dated Aug 4, 2026.
What is Parschauer Karah Herdman's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Parschauer Karah Herdman is listed as EVP and Chief Legal Officer.
What is Parschauer Karah Herdman's total buy and sell value in the current window?
Inside the rolling retention window, Parschauer Karah Herdman bought $0 and sold $488K based on SEC Form 4 filings.
What was Parschauer Karah Herdman's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,135 RARE shares on 2026-03-02, worth $185K, per SEC Form 4 filings.